[CYCC] YoY Quarter Result on 31-Mar-2010 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
19-May-2010
Financial Year
2010
Quarter
31-Mar-2010 [#Q1]
Profit Trend
QoQ- -17.85%
YoY- -0.95%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Revenue 212 161 192 271 228 177 52 26.36%
PBT -3,356 -3,123 -4,779 -5,244 -5,421 -6,927 -5,442 -7.73%
Tax -258 -168 -191 -133 -358 -675 -552 -11.89%
NP -3,082 -2,955 -4,588 -5,111 -5,063 -6,252 -4,890 -7.39%
Tax Rate - - - - - - - -
Total Cost 3,294 3,116 4,780 5,382 5,291 6,429 4,942 -6.53%
Ratio Analysis
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
NP Margin -1,453.77 -1,835.40 -2,389.58 -1,885.98 -2,220.61 -3,532.20 -9,403.85 -26.71%
Per Share
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
EPS -75.55 -90.66 -165.51 -270.70 -416.30 -514.06 -451.69 -25.75%
EPS Diluted -75.55 -90.66 -165.51 -270.70 -416.30 -514.06 -451.69 -25.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.